Albireo Pharma Inc.

NASDAQ: ALBO · Real-Time Price · USD
44.15
0.00 (0.00%)
At close: Mar 02, 2023, 10:00 PM

Albireo Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
40.58M
Cost of Revenue
1.36M
Gross Profit
39.22M
Operating Income
-123.48M
Interest Income
n/a
Pretax Income
-34.03M
Net Income
-151.35M
Selling & General & Admin
69.57M
Research & Development
82.52M
Other Expenses
10.62M
Operating Expenses
162.71M
Interest Expense
13.93M
Selling & Marketing Expenses
n/a
Cost & Expenses
164.06M
Income Tax Expense
117.32M
Shares Outstanding (Basic)
19.22M
Shares Outstanding (Diluted)
19.22M
EPS (Basic)
-7.87
EPS (Diluted)
-7.87
EBITDA
-19.82M
EBIT
-20.1M
Depreciation & Amortization
274K